Pfizer moves forward with once-daily version of weight loss pill after setbacks
The company plans to conduct studies in the second half of the year evaluating multiple doses of the drug. Source
Read More
Biotech and Pharmaceuticals
Investors want proof AI will aid drug discovery. Evidence may come in the second half
Nvidia is a fan of Recursion Pharmaceuticals. Data expected from the company will help determine valuations for stocks using AI
Read More
Novo Nordisk shares shrug off concerns over study linking weight loss drugs to rare eye condition
Novo Nordisk investors appeared unperturbed Thursday by a critical Harvard report that linked weight loss drugs to a rare eye
Read More
FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.
It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an
Read More
Rite Aid bankruptcy plan approved, cutting $2 billion in debt
Rite Aid used its bankruptcy to close hundreds of stores, sell its pharmacy benefit company Elixir, and negotiate settlements. Source
Read More
Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug data
Drugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant
Read More
Biden administration to lower costs for 64 drugs through inflation penalties on drugmakers
President Joe Biden has made lowering U.S. drug prices a key pillar of his health-care agenda and reelection platform for
Read More
Novo Nordisk’s Wegovy weight loss drug approved in China
Novo Nordisk said Tuesday that its Wegovy weight loss treatment has been approved in China for long-term weight management. Source
Read More
Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
The new plant in Clayton, North Carolina, will be responsible for filling and packaging syringes and injection pens for Wegovy,
Read More